Evidence map›Paper›PMID 42872108›Full record

ReviewFrontiers in immunology2026

MERS-CoV accessory ORF proteins in innate immune evasion: an evidence-graded functional framework.

Chunhua Wang, Xuhang Li, Yi Jiang, Jinhui Yang, Minghui Yang, Yang Yang, Mengjun Tang, Wenjie Tan, Ji Zhang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chunhua Wang *Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Xuhang Li *Department of Clinical Laboratory, Xiangyang Hospital of Traditional Chinese Medicine [Xiangyang Institute of Traditional Chinese Medicine], Xiangyang, Hubei, China.
Yi Jiang *Department of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Jinhui YangSchool of Clinical Medicine, Hubei University of Arts and Science, Xiangyang, Hubei, China.
Minghui YangSchool of Life Science, Key Laboratory of Molecular Medicine and Biotherapy, Beijing Key Laboratory of Mucosal Immunity Vaccines Against Respiratory Viruses, Beijing Institute of Technology, Beijing, China.
Yang YangNational Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Mengjun TangDepartment of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Wenjie TanNHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Ji ZhangDepartment of Central Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) is a merbecovirus associated with recurrent zoonotic spillover and severe lower-respiratory disease. Research has focused largely on DPP4-mediated entry, spike structure, replicase biology, neutralizing antibodies, and vaccines. However, the 3'-encoded accessory proteins are increasingly recognized as context-dependent modulators of viral fitness and pathogenesis. ORF4a binds double-stranded RNA (dsRNA) and suppresses MDA5- and PKR-dependent antiviral responses; ORF4b antagonizes OAS-RNase L and NF-κB signaling and contributes to inflammatory pathology in defined infection models; ORF5 modulates interferon and inflammatory responses in a genetic-background-dependent manner; and ORF8b interferes with MDA5- and HSP70-IKKϵ-dependent signaling, although its pathogenesis phenotype varies by experimental system and viral background. ORF3 shows HUWE1-regulated pro-apoptotic activity in ectopic-expression systems, but its role during authentic MERS-CoV infection remains unresolved. Our review organizes these findings by evidence type, pathway position, cell or tissue context, sampling time, and genetic-interaction evidence. This framework separates demonstrated mechanisms from inferred biological consequences and identifies the validation required before accessory-ORF biology can inform host-range assessment, therapeutic development, sequence surveillance, or rational attenuation.

Indexed as

Coronavirus InfectionsImmune EvasionImmunity, InnateMiddle East Respiratory Syndrome CoronavirusViral ProteinsViral Regulatory and Accessory ProteinsAnimalsHost-Pathogen InteractionsHumansSignal TransductionViral ProteinsViral Regulatory and Accessory Proteinsaccessory proteininnate immune evasionMERS-CoVORF3ORF4aORF4bORF5ORF8b

Identifiers

PMID42872108
PMCPMC13659741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.